Patent · US Active

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

US10953030B2 · kind B2 · utility

0Cited by
13References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2019
Grant dateMar 23, 2021
Priority date—
Expiry dateAug 5, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein, produce a synergistic effect on the inhibition of HCV polymerase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.